We’re proud to announce our lab’s latest publication in IEEE, where we introduce Vespa, a groundbreaking open-source validation framework for Continuous-Flow Microfluidic Devices (CFMDs), also known as biochips. These devices are essential for automated, cost-effective biomolecular analysis, but their design complexity often leads to challenges, particularly in large-scale microfluidic integration (mLSI) experiments.
Vespa efficiently addresses these challenges using logic expressions to validate Design-Objective-Constraint Compatibility (DOCC) in microfluidic designs. Unlike existing methods that struggle with large networks, Vespa mitigates undesired flow risks and reduces the human labor in validating complex microfluidic operations.
To demonstrate Vespa's practical impact, we conducted case studies using real-world CFMDs, which showed that it could eliminate over 90% of DOCC-related wet lab tests by identifying and correcting issues before fabrication. This streamlines the design process and significantly reduces experimental costs and time.
For a deeper dive into our findings, you can read the complete publication on IEEE Xplore:
Stay tuned as we continue to advance the microfluidic device design and validation field!
コメント